Tus kws kho mob
P6-17 A New Drug, Emflaza (deflazacort), Will Require Prior Authorization
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 27, 2017
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 3281 - 3290 ntawm 3669
Tus kws kho mob
P46-16 Changes in Medical Policy IV-87 Spinal Fusion: Lumbar
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 30, 2016
Tus kws kho mob
P25-16 Update to Attachment B: Definition of Outpatient Health Services Categories
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 06, 2016
Tus kws kho mob
P56-16 A New Drug, Dupilumab Will Require Prior Authorization
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 22, 2016
Tus kws kho mob
P56-17 Implementation of a Medical Drug Exclusions List
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 16, 2017
Tus kws kho mob
P5R1-17 Updated: Third Party Payments of Premium and/or Cost-Sharing
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 05, 2017
Tus kws kho mob
P14-16 Addition of Lazanda ® to Existing Drug-Related Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 29, 2016
Tus kws kho mob
P49-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Zavesca
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 27, 2016
Tus kws kho mob
P24-16 Providers will see a change in our Prior Authorization Process for Government Products
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2016
Tus kws kho mob
P15-16 Place of Service 53 will be Changed to a Facility Place of Service
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 07, 2016